Baupost Group’s Atara Biotherapeutics ATRA Stock Holding History

Baupost Group’s Portfolio ATRA Stock Details ATRA Fund Activity

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-9,773,616	Closed	-$14.5M	–	25
2023 Q3	$14.5M	Hold	9,773,616	–	–	0.28%	30
2023 Q2	$15.7M	Buy	9,773,616 +650,000	+7%	+$1.05M	0.28%	25
2023 Q1	$26.5M	Buy	9,123,616 +1,000,000	+12%	+$2.9M	0.45%	23
2022 Q4	$26.6M	Hold	8,123,616	–	–	0.43%	25
2022 Q3	$30.7M	Hold	8,123,616	–	–	0.53%	26
2022 Q2	$63.3M	Hold	8,123,616	–	–	0.94%	23
2022 Q1	$75.5M	Sell	8,123,616 -353,872	-4%	-$3.29M	0.81%	22
2021 Q4	$134M	Hold	8,477,488	–	–	1.32%	23
2021 Q3	$152M	Hold	8,477,488	–	–	1.39%	21
2021 Q2	$132M	Hold	8,477,488	–	–	1.07%	24
2021 Q1	$122M	Sell	8,477,488 -631,500	-7%	-$9.07M	0.97%	28
2020 Q4	$179M	Sell	9,108,988 -813,042	-8%	-$16M	1.65%	17
2020 Q3	$129M	Hold	9,922,030	–	–	1.39%	23
2020 Q2	$145M	Buy	9,922,030 +1,613,130	+19%	+$23.5M	1.8%	18
2020 Q1	$70.7M	Hold	8,308,900	–	–	1.04%	22
2019 Q4	$137M	Hold	8,308,900	–	–	1.51%	20
2019 Q3	$117M	Buy	8,308,900 +1,308,900	+19%	+$18.5M	1.33%	22
2019 Q2	$141M	Buy	7,000,000 +619,481	+10%	+$12.5M	1.27%	23
2019 Q1	$254M	Buy	6,380,519 +125,887	+2%	+$5M	2.13%	16
2018 Q4	$217M	Hold	6,254,632	–	–	1.89%	16
2018 Q3	$259M	Hold	6,254,632	–	–	1.98%	16
2018 Q2	$230M	Hold	6,254,632	–	–	2.01%	14
2018 Q1	$244M	Buy	6,254,632 +895,000	+17%	+$34.9M	2.35%	14
2017 Q4	$97M	Hold	5,359,632	–	–	0.96%	20
2017 Q3	$88.7M	Hold	5,359,632	–	–	1.11%	17
2017 Q2	$75M	Hold	5,359,632	–	–	0.86%	20
2017 Q1	$110M	Hold	5,359,632	–	–	1.3%	19
2016 Q4	$76.1M	Hold	5,359,632	–	–	0.99%	19
2016 Q3	$115M	Hold	5,359,632	–	–	1.63%	18
2016 Q2	$121M	Hold	5,359,632	–	–	1.64%	16
2016 Q1	$102M	Hold	5,359,632	–	–	1.47%	16
2015 Q4	$142M	Hold	5,359,632	–	–	2.57%	9
2015 Q3	$169M	Buy	5,359,632 +550,000	+11%	+$17.3M	2.81%	10
2015 Q2	$254M	Buy	4,809,632 +46,367	+1%	+$2.45M	4.23%	10
2015 Q1	$193M	Buy	4,763,265 +2,267,352	+91%	+$91.8M	3.24%	11
2014 Q4	$59.1M	Buy	+2,495,913	New	+$59.1M	1.16%	20